BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38178094)

  • 1. TIMELESS promotes reprogramming of glucose metabolism in oral squamous cell carcinoma.
    Chen Y; Han Z; Zhang L; Gao C; Wei J; Yang X; Han Y; Li Y; Zhang C; Wei Y; Dong J; Xun W; Sun W; Zhang T; Zhang H; Chen J; Yuan P
    J Transl Med; 2024 Jan; 22(1):21. PubMed ID: 38178094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
    Hou Z; Wu C; Tang J; Liu S; Li L
    Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of PER2 Promotes Tumor Progression by Enhancing Glycolysis via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Oral Squamous Cell Carcinoma.
    Long W; Gong X; Yang Y; Yang K
    J Oral Maxillofac Surg; 2020 Oct; 78(10):1780.e1-1780.e14. PubMed ID: 32615095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
    Zhu X; Du J; Gu Z
    Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PER1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the PER1/RACK1/PI3K signaling complex.
    Gong X; Tang H; Yang K
    Cell Death Dis; 2021 Mar; 12(3):276. PubMed ID: 33723221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling.
    Ma S; Chen Y; Quan P; Zhang J; Han S; Wang G; Qi R; Zhang X; Wang F; Yuan J; Yang X; Jia W; Qin W
    BMC Cancer; 2023 Mar; 23(1):280. PubMed ID: 36978001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0008068 facilitates the oral squamous cell carcinoma development by microRNA-153-3p/acylgycerol kinase (AGK) axis.
    Long Y; Li C; Zhu B
    Bioengineered; 2022 May; 13(5):13055-13069. PubMed ID: 35635053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation.
    Zhang G; Zhao X; Liu W
    Cancer Biol Ther; 2022 Dec; 23(1):243-253. PubMed ID: 35316145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circle RNA hsa_circRNA_100290 serves as a ceRNA for miR-378a to regulate oral squamous cell carcinoma cells growth via Glucose transporter-1 (GLUT1) and glycolysis.
    Chen X; Yu J; Tian H; Shan Z; Liu W; Pan Z; Ren J
    J Cell Physiol; 2019 Nov; 234(11):19130-19140. PubMed ID: 31187488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT1 regulated hexokinase-2 promoting glycolysis is involved in hydroquinone-enhanced malignant progression in human lymphoblastoid TK6 cells.
    Chen Y; Yang H; Chen S; Lu Z; Li B; Jiang T; Xuan M; Ye R; Liang H; Liu X; Liu Q; Tang H
    Ecotoxicol Environ Saf; 2022 Aug; 241():113757. PubMed ID: 35714482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression.
    Zhao H; Jiang R; Feng Z; Wang X; Zhang C
    J Transl Med; 2023 Nov; 21(1):833. PubMed ID: 37980488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of microRNA-218 promotes oral squamous cell carcinoma growth by targeting GLUT1 to affect glucose metabolism.
    Xu XJ; Yuan J; Sun WJ; Chen QY; Lin Y; Tang L; Liang LZ
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7726-7734. PubMed ID: 30536316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA PVT1 promotes tumor cell proliferation, invasion, migration and inhibits apoptosis in oral squamous cell carcinoma by regulating miR‑150‑5p/GLUT‑1.
    Li X; Ren H
    Oncol Rep; 2020 Oct; 44(4):1524-1538. PubMed ID: 32945498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Timeless promotes the proliferation of hepatocellular carcinoma cell by reprogramming of glucose metabolism].
    Zhang JS; Yuan P; Yan ZY; Lu R; Li B; Geng XE; Mu J; Zhang HX
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):499-505. PubMed ID: 30060357
    [No Abstract]   [Full Text] [Related]  

  • 15. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway.
    Yuan SF; Wang YM; Chan LP; Hung AC; Nguyen HDH; Chen YK; Hu SC; Lo S; Wang YY
    J Transl Med; 2023 Jul; 21(1):473. PubMed ID: 37461111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM31 promotes the progression of oral squamous cell carcinoma through upregulating AKT phosphorylation and subsequent cellular glycolysis.
    Sang SQ; Zhao YJ; Wang M; Zhong XQ; Yang ZC; Lu MM
    Neoplasma; 2023 Jun; 70(3):402-415. PubMed ID: 37498068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ITGB2-mediated metabolic switch in CAFs promotes OSCC proliferation by oxidation of NADH in mitochondrial oxidative phosphorylation system.
    Zhang X; Dong Y; Zhao M; Ding L; Yang X; Jing Y; Song Y; Chen S; Hu Q; Ni Y
    Theranostics; 2020; 10(26):12044-12059. PubMed ID: 33204328
    [No Abstract]   [Full Text] [Related]  

  • 18. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
    Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
    Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT1 acts as a potential tumor suppressor in oral squamous cell carcinoma.
    Kang YY; Sun FL; Zhang Y; Wang Z
    J Chin Med Assoc; 2018 May; 81(5):416-422. PubMed ID: 29050728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. circ_0004872 inhibits proliferation, invasion, and glycolysis of oral squamous cell carcinoma by sponged miR-424-5p.
    Dai Y; Zhu Y; Xu H
    J Clin Lab Anal; 2022 Jul; 36(7):e24486. PubMed ID: 35576499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.